These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2149685)

  • 1. Blood hyperviscosity and its relationship to progressive renal failure in patients with diabetic nephropathy.
    Gordge MP; Patel A; Faint RW; Rylance PB; Neild GH
    Diabet Med; 1990 Dec; 7(10):880-6. PubMed ID: 2149685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic alterations in long-term insulin-dependent diabetic patients with overt nephropathy: role of blood hyperviscosity and plasma protein changes.
    Solerte SB; Fioravanti M
    Clin Nephrol; 1987 Sep; 28(3):138-43. PubMed ID: 3665207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal blood rheology in progressive renal failure: a factor in non-immune glomerular injury?
    Gordge MP; Faint RW; Rylance PB; Neild GH
    Nephrol Dial Transplant; 1988; 3(3):257-62. PubMed ID: 3140097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemostatic activation and proteinuria as factors in the progression of chronic renal failure.
    Gordge MP; Leaker BR; Rylance PB; Neild GH
    Nephrol Dial Transplant; 1991; 6(1):21-6. PubMed ID: 2057112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy.
    Zimmermann J; Schramm L; Wanner C; Mulzer E; Henrich HA; Langer R; Heidbreder E
    Clin Nephrol; 1996 Oct; 46(4):230-6. PubMed ID: 8905207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of reduced red blood cell deformability and diabetic nephropathy.
    Brown CD; Ghali HS; Zhao Z; Thomas LL; Friedman EA
    Kidney Int; 2005 Jan; 67(1):295-300. PubMed ID: 15610255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma fibronectin, von Willebrand factor antigen, and blood rheology. Association with diabetic microvascular disease.
    Solerte SB; Piovella F; Viola C; Schianca GC; Gamba G; Fioravanti M; Ferrari E
    Acta Diabetol Lat; 1985; 22(3):239-46. PubMed ID: 3878055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chronic kidney disease on red blood cell rheology.
    Brimble KS; McFarlane A; Winegard N; Crowther M; Churchill DN
    Clin Hemorheol Microcirc; 2006; 34(3):411-20. PubMed ID: 16614465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemorheological Approach for Early Detection of Chronic Kidney Disease and Diabetic Nephropathy in Type 2 Diabetes.
    Lee S; Lee MY; Nam JS; Kang S; Park JS; Shin S; Ahn CW; Kim KR
    Diabetes Technol Ther; 2015 Nov; 17(11):808-15. PubMed ID: 26214546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood and plasma viscosity in diabetes: possible contribution to late organ complications?
    Schut NH; van Arkel EC; Hardeman MR; Bilo HJ; Michels RP; Vreeken J
    Diabetes Res; 1992 Jan; 19(1):31-5. PubMed ID: 1468184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood rheology and diabetic nephropathy.
    Simpson LO
    Diabetologia; 1990 Sep; 33(9):576-7. PubMed ID: 2253836
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship between autonomic function and plasma fibrinogen, viscosity, and elements of fibrinolytic activity in diabetic nephropathy.
    Weinrauch LA; Gleason RE; Keough J; D'Elia JA
    Am J Hypertens; 1997 Apr; 10(4 Pt 1):454-61. PubMed ID: 9128213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function.
    Lajer M; Tarnow I; Michelson AD; Jorsal A; Frelinger AL; Parving HH; Rossing P; Tarnow L
    Platelets; 2010; 21(7):525-32. PubMed ID: 20701458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of Shenqi Dihuang decoction on inflammatory factor, renal function and microcirculation in patients with early diabetic nephropathy].
    Wang MR; Yu LH; Wang TT; Wang YM; Han MX
    Zhongguo Zhong Yao Za Zhi; 2018 Mar; 43(6):1276-1281. PubMed ID: 29676140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diabetic patient with renal insufficiency.
    Vanhille P
    Diabetes Metab; 2000 Jul; 26 Suppl 4():67-72. PubMed ID: 10922976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of dietary protein restriction and influence of proteinuria on progression of type 2 diabetic renal failure].
    Okada T; Matsumoto H; Nakao T; Nagaoka Y; Shino T; Yoshino M; Hidaka H; Kanazawa Y
    Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):365-73. PubMed ID: 10998917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheological and microvascular parameters in diabetic peripheral neuropathy.
    Young MJ; Bennett JL; Liderth SA; Veves A; Boulton AJ; Douglas JT
    Clin Sci (Lond); 1996 Mar; 90(3):183-7. PubMed ID: 8777823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperviscosity and microproteinuria in central obesity: relevance to cardiovascular risk.
    Solerte SB; Fioravanti M; Pezza N; Locatelli M; Schifino N; Cerutti N; Severgnini S; Rondanelli M; Ferrari E
    Int J Obes Relat Metab Disord; 1997 Jun; 21(6):417-23. PubMed ID: 9192223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal ultrasonography is useful for evaluating diabetic renal failure.
    Nishimura M; Terawaki H; Hoshiyama Y; Joh K; Hamaguchi K; Yamada K
    Clin Nephrol; 2003 Mar; 59(3):174-9. PubMed ID: 12653259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.